Keren Tzarfaty: On the Therapeutic Applications of MDMA

CIIS Public Programs - Podcast tekijän mukaan CIIS Public Programs - Torstaisin

MDMA is currently in phase three of clinical trial research studies for the treatment of trauma in the United States, Canada, and Israel. In this episode, clinician and CIIS professor Gisele Fernandes-Osterhold has a conversation with Israel-based MAPS clinician-researcher Keren Tzarfaty on the benefits and therapeutic applications of MDMA assisted psychotherapy. Keren and Gisele go deep into the nature of the psychedelic experience, the principles that guide the therapeutic work, and the new paradigm this study offers to treatment of PTSD and to psychotherapy in general. This episode was recorded during a live online event on April 6, 2021. A transcript is available at ciispod.com. SCHEDULE UPDATE New episodes of our podcast will now be released every other Thursday. If you are a subscriber, the next episode after this one will appear in your feed and on ciispod.com on June 17th. To be sure you never miss an episode, find us and subscribe by searching for "CIIS Public Programs" in your preferred podcast app.

Visit the podcast's native language site